All posts by imreal

DiA Secures FDA Clearance and CE Mark for Additional AI-Based Ultrasound Analysis Solutions for Use on the COVID-19 Frontlines


DiA’s LVivo RV uses AI to immediately detect signs of right ventricle dysfunction

DiA Imaging Analysis, a leading provider of advanced AI-based solutions for ultrasound analysis, announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) 510(k) and a European CE mark for two additional AI-powered ultrasound analysis solutions.


  • LVivo RV is the first AI-based fully automated analysis of the heart’s right ventricle (RV) and can be used to diagnose and monitor right heart ailments in acute and chronic patients suspected to have RV injury, including those with COVID-19.
  • LVivo Bladder uses AI to deliver automated bladder volume measurements on ultrasound devices, significantly reducing patient scanning time and risk of infection.

Both solutions join DiA’s LVivo Toolbox, of now six FDA/CE-cleared AI-powered ultrasound solutions in total. The company was recently awarded a COVID-19-specific government grant from Israel’s Innovation Authority to accelerate access to its AI-based offerings in response to the COVID-19 pandemic.

“Physicians now face a host of new challenges and restrictions on the frontlines that underscores the critical role of ultrasound and value of having access to AI-powered solutions,” said Hila Goldman-Aslan, DiA’s CEO and Co-Founder. “With today’s FDA and CE approvals, DiA takes a big step toward strengthening our AI offerings for cardiac ultrasound while realizing our vision of making ultrasound analysis smarter and more accessible across a broader range of healthcare segments.”

There is growing evidence linking COVID-19 mortality and right ventricle heart failure. A study at Mount Sinai Morningside Hospital found that 31% of the patients hospitalized with COVID-19 had right ventricle failure, and that 41% of patients in this subset who died had signs of RV dilation or enlargement. By automatically providing quantified 2D analysis of the RV’s size and function, LVivo RV helps detect and monitor right heart failure. LVivo RV utilizes DiA’s flagship LVivo Artificial Intelligence platform to deliver faster, more accurate analysis while at the same time enabling clinicians to shorten patient scanning and evaluation time.

“The RV has always been very difficult to evaluate, due to its unique structure and location,” said Dr. Anthony M. Demaria, a leading cardiologist at University of California, San Diego (UCSD) Medical Center and a co-investigator of the multi-center study for LVivo RV. “This is further compounded by the complexity of the analysis itself, which relies on a combination of manual calculations and visual user input. LVivo RV is a welcome and very useful addition to clinicians’ toolbox for more quickly and effectively monitoring the right ventricle.”

Additional co-investigators of the study included Dr. David Rosenmann and Dr. Shemi Carasso at Israel’s Shaare Zedek Medical Center and Baruch Padeh Medical Center, respectively.

With LVivo Bladder, DiA extends its expertise beyond cardiology to abdominal ultrasound. Healthcare-associated urinary tract infections (UTIs) account for up to 40% of infections in hospitals and 23% of infections in the intensive care unit (ICU). LVivo Bladder enables ultrasound users to automatically and accurately measure bladder volume, which is currently done on cart-based systems manually or by dedicated bladder scanners. LVivo Bladder’s automated volume calculation turns any ultrasound device into a bladder scanner, minimizing patient scanning time and helping to prevent unnecessary catheterization to reduce the risk of infection.

About DiA Imaging Analysis:

DiA Imaging Analysis is a leading provider of AI-powered ultrasound analysis solutions that transform the way clinicians use and analyze ultrasound images. DiA was named one of eight companies to watch for AI imaging technology by DAIC Magazine and is leading the way in FDA/CE-cleared AI products for ultrasound. Its vendor neutral LVivo AI solutions use a combination of image processing, machine learning and deep neural network algorithms to automatically detect clinical parameters and abnormalities in ultrasound images. LVivo solutions allow clinicians with various levels of ultrasound experience to use and analyze ultrasound images on their ultrasound devices or healthcare IT system with increased speed, efficiency and accuracy. DiA currently serves thousands of end-users worldwide.

For additional information, please visit http://www.dia-analysis.com.

Share article on social media or email:

Mediaplanet and University of Pennsylvania Lung Transplant Patient Team up in the Fight for Healthy Lungs


News Image

About 65 million people suffer from chronic obstructive pulmonary disease, and 3 million die from it each year, making it the third leading cause of death worldwide.

Mediaplanet today announces the launch of this June’s edition of “Lung Health.” This campaign will advocate for clean air and what we can do to enjoy life with healthy lungs.

About 65 million people suffer from chronic obstructive pulmonary disease, and 3 million die from it each year, making it the third leading cause of death worldwide. About 334 million people suffer from asthma, the most common chronic disease of childhood, affecting 14 percent of all children globally. Dangers are lurking and actions must be taken to keep our planet safe and with the healthiest air possible. This campaign offers insight readers may have never known that will help them and their family and friends.

Sarcoidosis survivor Karen graces the cover of the print campaign. Karen shares her story of how she fought her battle with this disease and how Penn Medicine saved her. Penn Medicine was able to give her the transplant she needed. The recovery for Karen was long and hard, but she was able to live her life with her granddaughter to the fullest.

Karen states, “If you’re afraid, speak to someone. Penn Medicine’s Lung Transplant and Pulmonary teams have a wonderful support system, from the doctors to the nurses to the support groups to the patients. Speak to a specialist, take the chance; you won’t regret it.” Karen is one of the many lung disease survivors in this world. Her story is truly inspiring and is one of many similar successes.

The print component of “Lung Health” is distributed within today’s edition of USA Today in New York, Los Angeles, Boston, Chicago, Washington, D.C., Baltimore, Atlanta, and the Carolinas markets, with a circulation of approximately 200,000 copies and an estimated readership of 600,000. The digital component is distributed nationally through a vast social media strategy and across a network of top news sites and partner outlets. To view the digital campaign, visit: https://www.futureofpersonalhealth.com/campaign/lung-health/

This campaign was made possible with the support of the American Lung Association, LUNGevity, Cleveland Clinic, GO2 Foundation, Pulmonary Fibrosis Foundation, Weitz & Luxenberg, Penn Medicine, and Boehringer Ingelheim.

About Mediaplanet

Mediaplanet specializes in the creation of content marketing campaigns covering a variety of industries. We tell meaningful stories that educate our audience and position our clients as solution providers. Our unique ability to pair the right leaders with the right readers, through the right platforms, has made Mediaplanet a global content marketing powerhouse. Our award-winning stories have won the hearts of countless readers while serving as a valuable platform for brands and their missions. Just call us storytellers with a purpose. Please visit http://www.mediaplanet.com for more on who we are and what we do.

Press Contact:

Abigail Hanania

Abigail.hanania@mediaplanet.com

(646) 619-3119

Share article on social media or email:

Pilot Services, Inc. Offers Technology to Get People Safely Back to Work During Covid-19


News Image

This sophisticated equipment is an investment, but over time they reap savings for businesses who no longer have to hire extra cleaning staff, do special disinfection procedures, or worry about a contagious employee impacting their staff’s health and productivity.

As COVID-19 has amplified the need for employee health screening and better disinfected work spaces, the Chicago-area IT firm, Pilot Services, Inc. has responded by offering two technology products to get people back to work safely. The two products include the Automated AI Temperature Screening System from Richtech Systems and the Safezone 850M9 Decontamination Device & UV Cleaner from UV Cleaning Systems, Inc. Both are being sold on the Pilot Services, Inc. website https://pilotaiscan.com/ to its own clients, as well as any business needing to safeguard employees and workspaces during the pandemic.

“We are IT providers who specialize in servicing assisted living facilities, so we’ve witnessed firsthand the pain and fear of them not being able to admit visitors because of the Coronavirus. We’ve also watch them grapple with the challenge of keeping their facilities decontaminated daily for the health and safety of their employees,” said Kimberly Warren, president and CEO of Pilot Services, Inc. “As we could no longer service them onsite, we decided we could best serve them by doing the research to help them simplify the two biggest challenges facing them right now: making sure employees who report to work are virus-free, and keeping surface areas regularly disinfected.”

The first of the two products is the Automated AI Temperature Screening System, or AATSS. AATSS is a kiosk-style, contactless scanner that businesses can place at the entrance to their facility. In under three seconds, it screens workers, visitors, and guests for elevated body temperature using approved telethermographic technology. The user simply looks into the camera on the unit, which accurately performs the temperature scan, using AI technology to adjust for facemasks, eyeglasses, etc. The AATSS is virtually maintenance-free, and custom installation and configuration and is available from Pilot Services, Inc. for $3,250.

The other offering is the Safezone 850M9 and the M20-120 Decontamination Device and UVC Cleaner, which uses the same UVC light disinfection technology that has been used by hospitals to provide safe surface decontamination for decades. The technology is now FDA-approved for use in all offices and businesses. The units activates to zap 99.9967 percent of bacteria and microorganisms on surfaces, including COVID-19, with the blast of ultra-powered UVC light, strong enough to kill Staphylococcus Aureus at 16 ft (5m) in 10 minutes. Both units are larger, self-contained, contactless, portable, cylindrical, UV cleaning units that can easily be rolled between empty rooms. The 850M9 is the best value for commercial facilities and is available from Pilot Services, Inc. for $9,995; the stronger, feature-packed M20-120 is $19,999. Leasing options and volume discounts are available.

“This sophisticated equipment is an investment, but over time they reap savings for businesses who no longer have to hire extra cleaning staff, do special disinfection procedures, or worry about a contagious employee impacting their staff’s health and productivity,” said Warren. “With no end to COVID-19 in sight, it’s an option for any business owner seeking peace of mind.”

For more information about ordering, please visit PilotAIScan.com.

About Pilot Services, Inc.

Pilot Services, Inc. is a certified WBE, IT services and data recovery firm, which was launched as a pilot program with AT&T to offer IT services in 1988. Today, the company offers managed services, network installation, cabling, and cloud computing services with a team of more than 2,500 technicians, monitoring thousands of clients from their two locations near Chicago and Tucson. They specialize in servicing healthcare facilities. Visit Pilot Services, Inc. at http://www.pilotservicesinc.com.

Share article on social media or email:

ATS Hires Seasoned Sales Expert to Expand Disinfectant Distribution in Brazil


We are optimistic about the results we are seeing in Brazil as a result of Monty’s dedication and decades of experience. We anticipate that the successes found in this hard-hit country will lead to our further global expansion into other Latin American regions.

ATS, a leader in solution-based products for advanced water treatment, has hired Javier “Monty” Montalti as the company’s new South American Sales Manager. Montalti is an experienced international sales and operations professional with more than 20 years’ in the field.

Montalti is building a team of sales professionals to distribute ATS’s chlorine dioxide, a powerful disinfectant used to fight coronavirus, in Brazil — a country experiencing a spike in coronavirus fatalities.

“ATS is a progressive company that seeks out innovative technology to improve lives and eliminate harmful pathogens, ultimately making the world a healthier place,” Montalti said. “As a result, ATS has found ways to make schools, workspaces and public spaces healthier through the use of chlorine dioxide.”

Understanding the urgency and need to help the residents of Brazil, Montalti and his sales team will distribute chlorine dioxide to businesses, shopping districts and large residential areas throughout the most densely populated regions of the country. Simultaneously, Montalti is petitioning the Brazilian Health Regulatory Agency to expand distribution efforts.

“It has been heartbreaking to see the fear and devastation COVID-19 has caused across the globe,” said Richard Allred, president, CEO and managing partner of ATS. “We are optimistic about the results we are seeing in Brazil as a result of Monty’s dedication and decades of experience. We anticipate that the successes found in this hard-hit country will lead to our further global expansion into other Latin American regions.”

As of June 22, Brazil, a country of 212 million people, has seen 1,090,349 cases of coronavirus, the world’s 2nd highest number of confirmed cases, with a total of 50,737 deaths. The numbers continue to climb. Also as a result of the virus, the unemployment rate is expected to double from 11.6% to 23.8%.

In addition to helping eradicate the virus with its disinfectant, ATS and Montalti are creating jobs for people who have been laid off due to COVID-19.

“We are in the best place at the right time with the best people and the best product,” Montalti said. “Our product will bless the health and livelihood of many people in Brazil – in many different ways.”

For more information on ATS, visit ATSSmartSolutions.com.

About ATS

Founded in 1979, ATS – located in Midvale, Utah – is a forward-thinking, global company dedicated to providing safe and effective solutions to protect and improve the quality of life. ATS develops and deploys environmentally safe and highly effective products and equipment to make the world a cleaner, safer and healthier place. From kitchen countertops and office workspaces to massive lakes and water systems; ATS is making life safe.

Share article on social media or email:

Trusted Dentists in Midland, TX Reopen Practice, Offer High-Quality Care and New Safety Guidelines


Dentists from The Dental Studio of Midland

The Dental Studio of Midland Reopens with New Safety Measures

In order to preserve their patients’ health as well as their overall community’s health, they welcome Midland area residents to receive the care they need from a team they can trust.

The Dental Studio of Midland announces it is fully reopening its state-of-the-art practice for new and existing patients. Emergency dentistry, gum disease treatment, and even dental implants are all available from this one skilled practice. Amid the novel coronavirus outbreak, this team of dentists is eager to provide the dental care patients need for a healthy life, while also providing a comfortable and safe atmosphere for them to receive it. Following recommendations and guidelines set by the Centers for Disease Control and Prevention (CDC), the American Dental Association (ADA), along with local and federal authorities, The Dental Studio of Midland has implemented new measures for the safety of their patients, staff, and greater community.

The dentists at the Dental Studio of Midland, Drs. Tye Thompson, Jordon Green, and Mallory Layman recognize the connection oral health and overall health have. If left untreated symptoms like bleeding gums and gum recession can lead to gum disease. This infection can spread throughout the body and lead to chronic inflammation and a strained immune system. In order to preserve their patients’ health as well as their overall community’s health, they welcome Midland area residents to receive the care they need from a team they can trust.

Offering comprehensive and caring dentistry, these dentists’ primary goal is to allow their patients to live a healthy and confident life. In order to offer truly custom and life-changing care, they get to know each patient, his or her unique needs and expectations, and eventually develop a meaningful and lasting relationship. “I love being part of a relationship that helps people improve their life in one way or another,” says Dr. Green.

Among their comprehensive list of treatments is gum disease therapy. Offering gum disease diagnoses along with surgical and non-surgical treatments, they encourage anyone with bleeding or swollen gums or tooth sensitivity to receive an examination and find out if they have the first stage of this progressive disease, gingivitis. Those with tooth loss can also receive comprehensive dental implant solutions. Single to full mouth dental implant solutions are all possible from this team’s one location.

Infection control has always been a top priority of the Dental Studio of Midland. In addition to following the Occupational Safety and Health Administration (OSHA) guidelines, they have implemented additional safety measures for the comfort and safety of their patients and staff.


  • Patients will be asked screening questions prior to their appointments and upon entering the office.
  • Visitors are encouraged to use provided hand sanitizing stations upon entering the practice.
  • Magazines and other items that are difficult to clean have been removed from the waiting room.
  • Appointments will be staggered to reduce waiting times and make social distancing possible between patients.
  • Staff members will wear personal protective equipment (PPE) at all times with patients.
  • All patient rooms will be sterilized with EPA-approved chemicals in between each patient.

To learn more about the Dental Studio of Midland’s safety measures or to schedule a personalized consultation with one of their dentists, patients can call 432-687-0629 or visit http://www.midlanddentalstudio.com.

About the Dentists

The Dental Studio of Midland offers comprehensive and caring dental care to patients in Midland, TX. Committed to serving custom care that patients truly need, Drs. Tye Thompson, Jordon Green, and Mallory Layman build relationships with each patient in order to understand their unique needs and goals. Both Drs. Thompson and Green completed dental training at the prestigious University of the Pacific and continue to expand their knowledge in dentistry by attending multiple continuing education courses. Dr. Layman brings her experience from the University of Texas to the team. The Dental Studio of Midland is equipped with advanced dental technology to provide patients with the highest standard of care. Drs. Thompson, Green, and Layman all bring their unique art and “niche” to The Dental Studio of Midland. Some of the services offered are laser dentistry, Invisalign®, full mouth reconstruction, and sedation dentistry. The Dental Studio of Midland team is dedicated to providing the most efficient, least painful procedures for patients, and offer minimally invasive surgery whenever possible. To learn more about Drs. Thompson, Green, and Layman and the services offered at The Dental Studio of Midland, call 432-687-0629 or visit http://www.midlanddentalstudio.com.

Share article on social media or email:

Financial Recovery for Health Systems is at Least a Year Away; Going Digital Can Accelerate It


Healthcare leaders are adapting delivery models to support expanded access to digital care.

It is imperative for healthcare providers to consider the breadth of their care delivery and to ensure that patients’ financial experiences are at least as successful as their clinical experiences – Kevin Fleming, CEO, Loyale Healthcare

According to survey results published just last week by the American Medical Group Association (AMGA), “most medical groups and health systems expect to overcome COVID-19 revenue losses in a year or more, but about a quarter are still unsure when or if they will ever return to pre-COVID levels.” Noting the responses of leaders at 59 of the nation’s preeminent integrated health systems and 36 independent medical groups, survey results indicated that, “Nearly 23 percent of health system respondents said that they could not pinpoint when their revenues will return to pre-coronavirus levels.”

Healthcare providers of all sizes and types experienced a severe disruption in operations and revenue as the COVID-19 public health crisis began. Almost immediately, the health crisis led to a financial crisis – as providers invested heavily in supplies and capabilities to serve infected patients and revenues plummeted because elective and other “non-essential” procedures were cancelled or delayed to minimize the risk of patient exposure to COVID-19.

Other key findings in the survey results include the following:


  • Forty one percent of healthcare systems are forecasting it will be at least a year before revenues return to pre-COVID levels
  • Nearly twenty three percent of healthcare systems said it’s still unknown when their revenues will return to normal
  • Ninety two percent of healthcare systems expect an increase in personal protective equipment expenses (PPE)
  • Eight seven percent of healthcare systems expect increases in telehealth infrastructure costs

Some provider relief has been distributed by the government through the Coronavirus Aid, Relief and Economic Security (CARES) Act, enacted on March 27 of this year created a provider relief fund of $100 billion, but providers agree that more will be needed to help prevent lasting damage to the American healthcare system. “Health systems and medical groups are operating under a cloud of financial uncertainty that threatens their ability to continue to deliver the best care to their communities,” AMGA President and CEO Jerry Penso, M.D., M.B.A is quoted as saying. “We continue to urge congress to provide additional funding to stabilize the front lines of the COVID-19 crisis.”

That funding is struggling to make it through Congress. On May 15, the House of Representatives approved the Health and Economic Recovery Omnibus Emergency Solution (HEROES) Act, which would provide additional $100 billion – but the senate has not yet taken action on the bill. In a letter to senate leadership on behalf of its members, AMGA urged legislators to pass this critical relief, noting that, “This situation requires immediate assistance if our members are to survive and continue meeting the needs of patients – both during and after the pandemic.”

Expanding Access to Telehealth Virtual Care – A COVID-19 Success Story

One unchallengeable outcome of healthcare’s response to the COVID-19 crisis has been the tremendous success of telehealth. As a safe and cost-effective alternative to in-person office visits, telehealth was encouraged by temporarily relaxed restrictions and improved reimbursements from the Center for Medicare and Medicaid Services (CMS). The not-so-surprising result? The use and utility of telehealth has exploded during the last few months.

Noting that, “The public health emergency has forced providers across the nation to reevaluate the way they deliver care,” the AGMA letter points out that, “This pandemic has exposed the underlying flaws in the site-of-service limitations for telehealth services and how these limitations neglect the needs of many Medicare beneficiaries.” Given patient acceptance of telehealth and the attractive provider economics of care delivery via telehealth, permanently lifting Medicare’s restrictions makes sense – for providers and for patients.

Physicians agree. Writing on behalf of the American College of Physicians (ACP), Jacquiline Fincher, MD, MACP, President, composed a letter to CMS Administrator Seema Verma regarding, “ACP Recommendations for Maintaining Certain Telehealth Policies and Waivers after the Public Health Emergency.” In it, Ms. Fincher points out that, “In order to help reduce the spread of COVID-19, while providing as much ongoing and routine care to their patient populations as is feasible, physician practices across the country have worked to quickly shift much of their patient care services to virtual visits.”

Arguing that, “the patient care and revenue opportunities afforded by telehealth functionality will continue to play a significant role within the U.S. healthcare system and care delivery models, even after the Public Health Emergency is lifted,” the ACP seeks a number of revised policies to permanently extend telehealth and other “contactless” care delivery models by ensuring that they remain unencumbered by pre-COVID economic and competitive limitations.

Virtual Patient Care Outside the Clinical Experience

Health Systems, hospitals and other healthcare providers understand that patients’ experiences aren’t confined to medical considerations only. For many (if not most) patients, the financial dimension of care is pivotal to their overall patient-provider encounter. With more patients opting to interact with their providers digitally using telehealth or telephone (audio-only) services, they must now also interact with all the other provider participants in their care episode. These include admissions, registration – and perhaps most important – billing and payment.

With no in-office visit to secure the necessary patient information to confirm insurance eligibility, determine deductibles or calculate copayments, it becomes necessary to either handle these labor-intensive procedures over the phone or to deliver digitally. Digital delivery offers several compelling economic advantages. First, they can be automated to dramatically reduce the amount of staff time needed for most patient registrations. Second, digital patient financial engagement improves service by putting valuable personal patient information at their fingertips, right when they need it.

For example, Loyale Healthcare’s Patient Financial Manager™ is configured by some healthcare providers to automate the patient’s financial registration and insurance eligibility processes. With many Americans making care decisions based on their ability to afford their out-of-pocket, we also empower providers and patients with pre-service cost estimates. Even more important in the COVID and post-COVID eras, the platform makes it possible for providers to offer multiple payment scenarios, all personalized to optimize affordability and improve the probability of payment.

When the Customer is Always Right

Long before the COVID-10 Public Health Emergency began, healthcare consumers were making different choices about whether, where and how they wanted their healthcare. The crisis, in this instance, has accelerated an important consumer and social trend that was already under way. For decades, the healthcare industry was immune to the disruptions that affected nearly every other sector of the American economy. But when patients began bearing more and more of the financial responsibility for their care (now more than one third of provider revenue), that began to shift. We explored this phenomenon in an article published last summer, observing that millennials and younger generations were abandoning traditional primary care physician care delivery models in favor of more convenience and better value.

The COVID-19 crisis has accelerated and expanded that sentiment across the population at large. For the last three months, Americans have been working, socializing and shopping online and they’ve found out it works. Now, with more and more of them experiencing perfectly satisfactory care delivery via telehealth, the genie is out of the bottle.

We at Loyale agree with the industry leaders cited in this article. Telehealth will continue to be an important part of the American healthcare landscape long after the COVID-19 crisis is over. At this important inflection point, it is imperative for healthcare providers to consider the breadth of their care delivery and to ensure that patients’ financial experiences are at least as successful as their clinical experiences. For providers, success will depend on it.

Kevin Fleming is the CEO of Loyale Healthcare

About Loyale

Loyale Patient Financial Manager™ is a comprehensive patient financial engagement technology platform leveraging a suite of configurable solution components including predictive analytics, intelligent workflows, multiple patient financing vehicles, communications, payments, digital front doors and other key capabilities.

Loyale Healthcare is committed to a mission of turning patient responsibility into lasting loyalty for its healthcare provider customers. Based in Lafayette, California, Loyale and its leadership team bring 27 years of expertise delivering leading financial engagement solutions for complex business environments. Loyale currently serves approximately 12,000 healthcare providers across 48 states. Loyale is proud to have an enterprise-level strategic partnership with Parallon which includes the deployment of Loyale’s industry leading technology at all HCA hospitals and Physician Groups.

New London, CT Periodontist, Drs. Gregory Toback and Marianne Urbanski, Make Top Dentist List by Connecticut Magazine Yet Again


Drs. Gregory Toback and Marianne Urbanski, Award-Winning Periodontists in New London, CT

Drs. Gregory Toback and Marianne Urbanski, Award-Winning Periodontists in New London, CT

Finding out what’s really important to our patients is at the core of our process here.

Drs. Gregory Toback and Marianne Urbanski are honored yet again on Connecticut Magazine’s 2020 Top Dentist list within the Periodontics category. As specialists, this team of periodontists offers high-quality care from their two practice locations in New London, CT and Westerly, RI. Laser gum disease therapy, minimally invasive gum recession treatment, and life-changing dental implants are all available from their state-of-the-art practice Shoreline Periodontics.

Authorities in periodontology, Drs. Toback and Urbanski frequently speak on advanced periodontal techniques across the country and even host two study clubs: Shoreline Periodontics Hygiene Study Club and Synergy Study Club. Amid the COVID-19 pandemic they have been highly sought after for webinars on the oral-systemic connection as well as the latest advancements in dentistry.

As a result, it is easy to see why they have been placed on this honored list for so many consecutive years. The Connecticut Magazine creates an exclusive poll to form the Top Dentists list each year. Nominated and voted on by their peers, Drs. Toback and Urbanski were both individually honored on this prestigious list.

Shoreline Periodontics combines decades of specialized training and experience with minimally invasive in-house technology to offer a truly unique experience. Both have received certifications to provide the revolutionary Chao Pinhole® Surgical technique that eliminates the need for incisions when reversing the effects of gum recession. For gum disease treatment, they offer comprehensive care including LANAP®. This laser gum surgery technique is the only laser dentistry solution FDA-cleared to not only eradicate disease-causing bacteria, but also regenerate tissue lost to infection.

As implant specialists, they offer single dental implant treatments all the way to life-changing full mouth dental implant solutions for those with tooth loss. In many cases these dental implant solutions can even be offered in just one day, limiting visits to the office and time spent without a complete and healthy smile.

Beyond modern techniques and technology, they strive to take a unique approach to care. “Many of the patients we see here at Shoreline Periodontics have had a history of chronic failed dentistry and complex problems,” says Dr. Toback, “Finding out what’s really important to our patients is at the core of our process here.” He continues to explain how the care they offer is truly individualized to the needs of their patients; they do not offer one-size-fits-all solutions.

Those interested in seeing a team of periodontists honored on the Top Dentist list by Connecticut Magazine, can call Shoreline Periodontics’ New London location at 860-443-2428 or 401-596-0000 for the Westerly, RI office and schedule a personalized consultation. Those interested in learning more about this team can read more on their website http://www.shorelineperio.com.

About the Periodontists

Shoreline Periodontics is a periodontal practice offering personalized dental care for patients since 1998 and is located in New London, CT and Westerly, RI. Leading board-certified periodontist, Dr. Gregory A. Toback, received his B.A. from St. John’s University and his Doctorate of Dental Medicine from the University of Connecticut. He also received advanced training in periodontics and dental implants at the University of Texas Health Science Center in San Antonio. Dr. Marianne Urbanski has been voted one of Connecticut’s top dentists for more than seven years by Connecticut Magazine. Dr. Urbanski graduated cum laude from the College of Holy Cross in Worcester, Massachusetts where she earned a Bachelors’ degree in Biology. She also received her Doctor of Dental Medicine degree and her Masters’ of Dental Science degree from the University of Connecticut Dental School. Dr. Urbanski and Dr. Toback pride themselves on offering caring, professional treatment to each patient. Dr. Toback and Dr. Urbanski focus on minimally invasive surgeries including LANAP® laser gum surgery and are certified to offer the Chao Pinhole Surgical Technique™ for treatment of gum recession. To learn more about Shoreline Periodontics and their dental services visit their website at http://www.shorelineperio.com or call 860-443-2428 for the New London, CT location, or 401-596-0000 for the Westerly, RI office.

Share article on social media or email:

Sellers Dorsey Welcomes Melinda Braithwaite as Vice President of Administration


Sellers Dorsey announced today the firm has hired Melinda (Mindy) Braithwaite as Vice President of Administration. The firm created this new senior leadership role to guide the company’s increasing investments in human capital, technology, and facilities. Ms. Braithwaite brings extensive expertise in business and human resource management, which she has used throughout her career to assist organizations pursuing strategic growth initiatives.

Sellers Dorsey has seen tremendous growth over the past three years. In anticipation of continuing this strategic growth, Ms. Braithwaite will provide leadership on a range of activities that are fundamental to the functioning of the firm, including talent acquisition, training, performance management, IT infrastructure and security, and physical infrastructure.

“Our firm is extremely fortunate to have highly capable staff who have fueled our growth, allowing us to help our clients succeed for 20 years,” said Martin Sellers, Founder and CEO of Sellers Dorsey. “Mindy is the ideal addition to our team, and we are excited about what we will all be able to do with her leadership and support now and in the future.”

Ms. Braithwaite’s background in business and human resource leadership includes 20+ years of experience across a range of industries, as an employee and consultant for growing organizations. She has served in executive roles in both operations and human capital management, and she has been recognized for building the business processes and infrastructure necessary for teams to produce outstanding results. Additionally, Ms. Braithwaite has executive experience in the business of health care, having overseen human resources functions for a health care provider in an earlier position.

“Sellers Dorsey has built a great culture, developed a team with exceptional skills and deep experience in Medicaid financing, policy, and strategy, and is delivering results to its clients,” said Ms. Braithwaite. “In my experience, adding the right management of people, process, and technology to a firm that’s on such a strong trajectory enables its team to realize incredible potential for its clients and the people they serve, so I feel honored and thrilled to now be a part of it.”

Based near Philadelphia, Pennsylvania, Ms. Braithwaite joins Sellers Dorsey as a member of its corporate management team and will officially be based in the company’s headquarters in Philadelphia.

About Sellers Dorsey

Sellers Dorsey consists of an industry-leading team of consultants and thought leaders from the worlds of policy, government, business, and industry, allowing the firm to provide a fully integrated suite of services to clients. Sellers Dorsey has a deep understanding of Medicaid, having consulted in over 30 states on a range of financing, policy, and operational projects, as well as Medicare topics. Its reputation is one of creativity and accomplishment. Learn more at sellersdorsey.com.

Share article on social media or email:

27th Annual FSHD International Research Congress Goes Virtual


Logo of 2020 FSHD International Research Congress - Now Virtual

“The FSHD International Research Congress serves a more important role than ever to speed up progress toward delivering effective treatments to our patients and families.”

The FSHD Society announced the opening today of its 27th annual International Research Congress (IRC), which is being conducted entirely online for the first time in the organization’s history. The conference is widely seen as the premier global platform for the discussion and dissemination of state-of-the-art research on facioscapulohumeral muscular dystrophy (FSHD). A record 210 researchers, clinicians, industry representatives and patient advocates are attending.

“Due to the global COVID-19 crisis, we have deployed a robust virtual conference platform for the 2020 IRC which has opened the opportunity to participate for many researchers who previously could not afford the time or cost of travel,” noted Jamshid Arjomand, PhD, chief science officer of the Society.

Researchers who have convened at this gathering since 1994 have helped drive fundamental discoveries, arriving at a broad consensus on a central hypothesis of the genetic basis of FSHD, development of cellular and animal models, identification of multiple therapeutic targets, and the validation of clinical outcome measures. These fundamental discoveries and collaborations have advanced the field, prompting observational and clinical studies – including an ongoing Phase 2b clinical trial for the first disease-modifying therapy for FSHD as well as a large natural history study called ReSOLVE. These studies, as well as other clinical research, have responded to the challenges of collecting data while keeping volunteers safe during the COVID-19 pandemic.

The program committee made special efforts to attract clinical and industry researchers, as advancement of drug development brings greater urgency to improving the understanding of the clinical features of FSHD, genotype-phenotype correlations, natural history, and evaluation of disease progression. As a result, the number of attendees and scientific presentations has nearly doubled over the past two years.

A growing number of companies have elected to sponsor the FSHD International Research Congress as they enter the field of FSHD diagnostics and therapy development. This year’s foundation and industry supporters include: Association Français Contre les Myopathies, Avidity, Bionano, Dyne Therapeutics, Fulcrum Therapeutics, Genomic Vision, miRecule, Muscular Dystrophy Association, National Institutes of Health, PerkinElmer Genomics, and the University of Nevada Reno.

“With the recent advances in FSHD studies now including large sets of data, greater availability of biomaterials from multiple large research initiatives, and the rapid approach of more clinical trials,” the program committee stated. “The FSHD International Research Congress serves a more important role than ever: to ensure dissemination of the latest ideas and discussion of the field’s needs and priorities, combined with collaboration and coordination, to speed up progress toward delivering effective treatments to our patients and families.”

About the FSHD Society

The FSHD Society is the world’s largest research-focused patient organization for facioscapulohumeral muscular dystrophy (FSHD), one of the most prevalent forms of muscular dystrophy. The Society has catalyzed major advancements and is accelerating the development of treatments and a cure to end the pain, disability, and suffering endured by one million people worldwide who live with FSHD. The FSHD Society has transformed the landscape for FSHD research and is committed to making sure that no one faces this disease alone. The Society offers a community of support, news, and information through its website at https://www.fshdsociety.org.

Share article on social media or email:

Leading Black Woman-Owned Marketing Firm Pivots to Join PPE Supply Chain and Help Essential Workers


Impact Consulting Enterprises supplied Personal Protective Equipment to organizations in need during COVID-19.

Impact’s PPE Supplies Were Sent to Those In Need

“We put our crisis communication skills to use and shored up a portion of the PPE supply chain for those in need. It only made sense. We did what we could to help others save lives.” – Impact President and CEO Cheryl McCants

Impact Consulting Enterprises (Impact), an award-winning minority and woman-owned strategic communication, marketing, and public relations firm, took a hands-on approach to help others when the COVID-19 pandemic hit the United States.

When COVID-19 struck the New York and New Jersey area in March, Team Impact diverted their focus from marketing, website design, and development, and dedicated themselves to helping others.

Impact President and CEO Cheryl McCants activated her supply chain to temporarily join the Personal Protective Equipment (PPE) network. McCants quickly began searching for reliable national and international suppliers. Impact did not waste a moment and soon acquired masks, gloves, hand sanitizers, wipes, and other PPE for hospitals, schools, utility companies, and other organizations in need.

“When I learned of the many challenges that procurement officers faced in identifying legitimate suppliers for masks, gloves, and other types of PPE, we instinctively jumped in to help,” said Impact Consulting Enterprises CEO and founder Cheryl McCants. “While we are not doctors, grocery workers, or first responders, Team Impact consists of great researchers and crises managers. We put our crisis communication skills to use and shored up a portion of the PPE supply chain for those in need. It only made sense. We did what we could to help others save lives.”

Highlights of Impact’s tremendous efforts include:


  • 50,000 masks to Newark, NJ’s University Hospital
  • 12,000 masks to Princeton, NJ’s Eden School for Autistic Children
  • 10,000 gloves to Massachusetts’ Veterans Administration Hospital
  • Nearly 300,000 sanitizing wipes to utility companies
  • Hundreds of masks to various NJ-based cleaning companies

Reliability, efficiency, and expediency reigned. Robert Sharbaugh, University Hospital’s acting director of Supply Chain Management, explains, “We had an immediate need for additional PPE supplies. Impact’s Newark office is located less than a mile away from University Hospital, so working with Cheryl and her team was an easy, trustworthy and close-to-home solution for the hospital.”

The team worked diligently behind the scenes to source reliable PPE for those on the frontlines in the battle against COVID-19. And, Impact certainly did not make this pivot for profit, as their PPE engagement yielded significantly lower earnings than their standard communication work. As the need for PPE sourcing settles down McCants looks forward to resuming her team’s focus on marketing. Impact continues to leverage their multitude of connections to help those in need and speak out against injustice everywhere.

About Impact Consulting Enterprises

Impact Consulting Enterprises, found on the web at https://www.eimpactconsulting.com is a minority, woman-owned strategic communication, marketing, public relations, website design and development firm founded in 1989 by business strategist and communication professional, Cheryl McCants. Foundations, corporations, small businesses, and government agencies partner with Impact to tell their untold stories to diverse audiences including women, millennials, genZers, baby boomers, Latino-, Asian- and African Americans. Impact, A+ rated by the Better Business Bureau, is HUBZone, WBE, WOSB, SBE, MBE, and 8A certified. We tell your stories!

Share article on social media or email: